Mangaluru: Complex surgery saves woman’s leg from amputation

Bengaluru, Jun 25: Former Karnataka chief minister and Janata Dal (Secular) leader HD Kumaraswamy on Wednesday claimed that there are shortage of beds and ventilators to treat COVID-19 patients in the state.

In a series of tweets, he targetted the Karnataka government on COVID-19 management.

"The state government has failed to provide adequate treatment to those infected with corona. There are no beds and no ventilators to treat more than four thousand patients. Self-induced lockdown is the only solution," he tweeted.

In his subsequent tweet, he said, "Residents of the state, including Bangalore, now have only one way to escape from COVID-19. Stay at home and celebrate yourself as a self-proclaimed lockdown. Money is not more important than life. Your life is in your hands now."

In another tweet, former Chief Minister alleged that the government has fixed Rs 10-15,000 per day for COVID-19 treatment in private hospitals.

"The state government is also saying this indirectly. The 'home remedy' in the home is to stay at home and be safe. The government has fixed Rs 10-15,000 per day for the treatment of this infection in private hospitals. How poor can afford it while upper class can't afford," he tweeted.

"If four members of a family infected with corona, the cost of treatment for a 15-day treatment at a private hospital is Rs 5-6 lakh. Where do the poor bring that Much money? We must save our lives while the government is sitting incapable. This is my concern for the people of the state," he said in another tweet.

In a video message that HD Kumaraswamy demanded the state government to give all kinds of safety and security to the students who are writing the SSLC exam tomorrow.
HD Kumaraswamy also urged students to be careful.

About 8,48,203 students will appear in the Secondary School Leaving Certificate (SSLC) examination tomorrow, said Karnataka Health Minister B Sriramulu on Wednesday.

New Delhi, May 1: The Ministry of Home Affairs (MHA) on Friday issued an order under the Disaster Management Act, 2005 to further extend the lockdown for a further period of two weeks beyond May 4.

The current lockdown period is scheduled to end on May 3.

"After a comprehensive review and in view of the lockdown measures having led to significant gains, the COVID-19 situation in the country, Ministry of Home Affairs issued an order under the Disaster Management Act, 2005, today, to further extend the lockdown for a further period of two weeks beyond May 4, 2020," read the order of the Home Ministry.

In red zones and outside containment zones, certain activities including plying of cycle rickshaws and auto-rickshaws, taxis and cab aggregators, intra-district and inter-district plying of buses and barber shops, spas and salons will be prohibited in addition to those prohibited throughout India.

A limited number of activities will remain prohibited across the country, irrespective of the zone, including travel by air, rail, metro and inter-state movement by road, running of schools, colleges, and other educational and training/coaching institutions, the order said.

This came after Prime Minister Narendra Modi's meeting with chief ministers of several states last month where some of them suggested extension of lockdown.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.